Javascript must be enabled to continue!
Spectrum of Microorganisms, Antibiotic Resistance Pattern, and Treatment Outcomes Among Patients With Empyema Thoracis: A Descriptive Cross-Sectional Study From the Bahawal Victoria Hospital Bahawalpur, Punjab, Pakistan
View through CrossRef
Background: This study involves the analysis of spectrum of microorganisms, antibiotic resistance pattern, and treatment outcomes among empyema thoracis patients. This study also analyzes the factors associated with unsuccessful treatment outcome and duration of hospital stay among the patients.Methods: This was a descriptive, cross-sectional study carried out in the Pulmonology Ward of the Bahawal Victoria hospital, Bahawalpur, Pakistan. All patients with empyema thoracis registered at the study site during the period of 1 year were included in the study. Multivariate regression analysis was used to analyze the factors associated with duration of hospital stay and unsuccessful treatment outcome among the patients.Results: A total 110 patients were included in the study. Most of the patients (n = 73, 66.4%) were treated with piperacillin/tazobactam alone and in combination with either one or more than one antibiotics as an empiric therapy. Culture was positive in 58 (52.7%) patients and the most commonly identified organisms included, gram-negative Pseudomonas aeruginosa (n = 20; 18.8%) and Klebsiella sp. (n = 11, 10%) followed by same proportion of E. coli. The most commonly identified bacterial isolates showed high level of resistance against antibiotics used as an empiric therapy, while these showed low level of resistance against amoxicillin, clarithromycin, ertapenem, colistin, tigecycline, fosfomycin, rifampicin, and vancomycin. In this study, 82 (74.5%) patients successfully completed the treatment, while 12 (11%) showed no clinical improvement, 5 (4.5%) lost to follow up and 11 (10%) died. In multivariate binary logistic regression analysis, none of the patient attributes were significantly associated with unsuccessful treatment outcome, while in multivariate linear regression analysis, the factors which were significantly associated with duration of hospital stay included; duration of symptoms <2 weeks prior to admission (p = 0.008, beta = −0.247) and resistance to five antibiotic classes (p = 0.02, beta = 0.280).Conclusion: Close to 25% of the patients did not complete the treatment successfully. Most of the common bacterial isolates showed high level of resistance against the broad-spectrum antibiotics used as an empiric therapy. This is alarming. However, better sensitivity of common bacterial isolates against standardized first line treatment for empyema thoracis is promising.
Title: Spectrum of Microorganisms, Antibiotic Resistance Pattern, and Treatment Outcomes Among Patients With Empyema Thoracis: A Descriptive Cross-Sectional Study From the Bahawal Victoria Hospital Bahawalpur, Punjab, Pakistan
Description:
Background: This study involves the analysis of spectrum of microorganisms, antibiotic resistance pattern, and treatment outcomes among empyema thoracis patients.
This study also analyzes the factors associated with unsuccessful treatment outcome and duration of hospital stay among the patients.
Methods: This was a descriptive, cross-sectional study carried out in the Pulmonology Ward of the Bahawal Victoria hospital, Bahawalpur, Pakistan.
All patients with empyema thoracis registered at the study site during the period of 1 year were included in the study.
Multivariate regression analysis was used to analyze the factors associated with duration of hospital stay and unsuccessful treatment outcome among the patients.
Results: A total 110 patients were included in the study.
Most of the patients (n = 73, 66.
4%) were treated with piperacillin/tazobactam alone and in combination with either one or more than one antibiotics as an empiric therapy.
Culture was positive in 58 (52.
7%) patients and the most commonly identified organisms included, gram-negative Pseudomonas aeruginosa (n = 20; 18.
8%) and Klebsiella sp.
(n = 11, 10%) followed by same proportion of E.
coli.
The most commonly identified bacterial isolates showed high level of resistance against antibiotics used as an empiric therapy, while these showed low level of resistance against amoxicillin, clarithromycin, ertapenem, colistin, tigecycline, fosfomycin, rifampicin, and vancomycin.
In this study, 82 (74.
5%) patients successfully completed the treatment, while 12 (11%) showed no clinical improvement, 5 (4.
5%) lost to follow up and 11 (10%) died.
In multivariate binary logistic regression analysis, none of the patient attributes were significantly associated with unsuccessful treatment outcome, while in multivariate linear regression analysis, the factors which were significantly associated with duration of hospital stay included; duration of symptoms <2 weeks prior to admission (p = 0.
008, beta = −0.
247) and resistance to five antibiotic classes (p = 0.
02, beta = 0.
280).
Conclusion: Close to 25% of the patients did not complete the treatment successfully.
Most of the common bacterial isolates showed high level of resistance against the broad-spectrum antibiotics used as an empiric therapy.
This is alarming.
However, better sensitivity of common bacterial isolates against standardized first line treatment for empyema thoracis is promising.
Related Results
Evolution of Antimicrobial Resistance in Community vs. Hospital-Acquired Infections
Evolution of Antimicrobial Resistance in Community vs. Hospital-Acquired Infections
Abstract
Introduction
Hospitals are high-risk environments for infections. Despite the global recognition of these pathogens, few studies compare microorganisms from community-acqu...
Open thoracotomy and decortication for chronic empyema thoracis: Our experience
Open thoracotomy and decortication for chronic empyema thoracis: Our experience
Empyema thoracis is defined as the presence of pus in the pleural space or a purulent pleural effusion. Chronic empyema is characterized by thickened visceral and parietal peels, w...
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Abstract
Introduction
Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...
The role of medical thoracoscopy in the management of empyema
The role of medical thoracoscopy in the management of empyema
Abstract
Background
Empyema thoracis is defined as accumulation of pus in the pleural space. Despite advanced medical diagnostic and therapeutic met...
Microbiological study of empyema thoracis among children in a tertiary care hospital
Microbiological study of empyema thoracis among children in a tertiary care hospital
Background: Empyema thoracis is a condition resulting in the accumulation of purulent fluid in the pleural cavity. It is a common source of illness among young children and is the ...
Microbiological study of empyema thoracis among children in a tertiary care hospital
Microbiological study of empyema thoracis among children in a tertiary care hospital
Background: Empyema thoracis is a condition resulting in the accumulation of purulent fluid in the pleural cavity. It is a common source of illness among young children and is the ...
Association between Awareness on Antibiotic Resistance and Antibiotic Misuse Among Saudi University Students
Association between Awareness on Antibiotic Resistance and Antibiotic Misuse Among Saudi University Students
Background:
Saudi Arabia has the highest prevalence of resistant pathogens in the Gulf Region, with a rapid increase in antibiotic resistance seen in recent years. ...
Occurrence and Management of Empyema Thoracis During Covid-19 Times
Occurrence and Management of Empyema Thoracis During Covid-19 Times
Introduction: Empyema is defined as an infected pleural fluid collection, evidenced either by purulent fluid
or the presence of bacterial organisms. The aim of this study is to hig...

